Molecule Details
| InChIKey | QNJQVLYQHWMMHP-UHFFFAOYSA-N |
|---|---|
| Compound Name | [1-(4-Sulfamoylphenyl)triazol-4-yl]methyl 2-(1,3-benzodioxol-5-ylmethyl)-1,3-dioxoisoindole-5-carboxylate |
| Canonical SMILES | NS(=O)(=O)c1ccc(-n2cc(COC(=O)c3ccc4c(c3)C(=O)N(Cc3ccc5c(c3)OCO5)C4=O)nn2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.47 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q16790 | CA9 | Homo sapiens | Human | PF00194 | 7.6 | Ki | ChEMBL |
| P00915 | CA1 | Homo sapiens | Human | PF00194 | 7.6 | Ki | ChEMBL |
| O43570 | CA12 | Homo sapiens | Human | PF00194 | 7.6 | Ki | ChEMBL |
| P00918 | CA2 | Homo sapiens | Human | PF00194 | 7.4 | Ki | ChEMBL |
| P22748 | CA4 | Homo sapiens | Human | PF00194 | 7.2 | Ki | ChEMBL |